Morgans analyst Iain Wilkie sat down with Leo Lee, CEO of ASX listed regenerative medicine player Regeneus (ASX:RGS). The two speak on its recent partnership deal for osteoarthritis in Japan and what it means for the company.

Under the microscope: Opyl (ASX:OPL) - Michelle Gallaher, Chief Executive Officer

A series of podcasts that include interviews with executives from ASX-listed companies and updates on the healthcare sector.